scholarly journals Hyperosmia in Lyme disease

2014 ◽  
Vol 72 (8) ◽  
pp. 596-597 ◽  
Author(s):  
Basant K. Puri ◽  
Jean A. Monro ◽  
Peter O. O. Julu ◽  
Michele C. Kingston ◽  
Mussadiq Shah
Keyword(s):  
Lyme Disease ◽  
Body Mass ◽  
Systematic Study ◽  
Controlled Study ◽  
Cranial Neuropathy ◽  
Neurological Involvement ◽  
Sensory Sensitivity ◽  
Sense Of Smell ◽  
Control Subjects

Neurological involvement in Lyme disease has been reported to include meningitis, cranial neuropathy and radiculoneuritis. While it is known that in some cases of asceptic meningitis patients may develop hyperosmia, the association between hyperosmia and Lyme disease has not previously been studied. Objective To carry out the first systematic study to ascertain whether hyperosmia is also a feature of Lyme disease. Method A questionnaire regarding abnormal sensory sensitivity in respect of the sense of smell was administered to 16 serologically positive Lyme disease patients and to 18 control subjects. Results The two groups were matched in respect of age, sex and body mass. None of the 34 subjects was suffering from migraine. Eight (50%) of the Lyme patients and none (0%) of the controls suffered from hyperosmia (p=0.0007). Conclusion This first systematic controlled study showed that Lyme disease is associated with hyperosmia.

Decreased Bone Density in Adolescent Girls With Anorexia Nervosa

PEDIATRICS ◽  
1990 ◽  
Vol 86 (3) ◽  
pp. 440-447 ◽  
Author(s):  
Laura K. Bachrach ◽  
David Guido ◽  
Debra Katzman ◽  
Iris F. Litt ◽  
Robert Marcus
Keyword(s):  
Bone Mineral Density ◽  
Body Mass Index ◽  
Anorexia Nervosa ◽  
Bone Density ◽  
Bone Mass ◽  
Body Mass ◽  
Bone Mineral ◽  
Whole Body ◽  
Mineral Density ◽  
Control Subjects

Osteoporosis develops in women with chronic anorexia nervosa. To determine whether bone mass is reduced in younger patients as well, bone density was studied in a group of adolescent patients with anorexia nervosa. With single- and dual-photon absorptiometry, a comparison was made of bone mineral density of midradius, lumbar spine, and whole body in 18 girls (12 to 20 years of age) with anorexia nervosa and 25 healthy control subjects of comparable age. Patients had significantly lower lumbar vertebral bone density than did control subjects (0.830 ± 0.140 vs 1.054 ± 0.139 g/cm2) and significantly lower whole body bone mass (0.700 ± 0.130 vs 0.955 ± 0.130 g/cm2). Midradius bone density was not significantly reduced. Of 18 patients, 12 had bone density greater than 2 standard deviations less than normal values for age. The diagnosis of anorexia nervosa had been made less than 1 year earlier for half of these girls. Body mass index correlated significantly with bone mass in girls who were not anorexic (P < .05, .005, and .0001 for lumbar, radius, and whole body, respectively). Bone mineral correlated significantly with body mass index in patients with anorexia nervosa as well. In addition, age at onset and duration of anorexia nervosa, but not calcium intake, activity level, or duration of amenorrhea correlated significantly with bone mineral density. It was concluded that important deficits of bone mass occur as a frequent and often early complication of anorexia nervosa in adolescence. Whole body is considerably more sensitive than midradius bone density as a measure of cortical bone loss in this illness. Low body mass index is an important predictor of this reduction in bone mass.

Carbohydrate loading failed to improve 100-km cycling performance in a placebo-controlled trial

2000 ◽  
Vol 88 (4) ◽  
pp. 1284-1290 ◽  
Author(s):  
Louise M. Burke ◽  
John A. Hawley ◽  
Elske J. Schabort ◽  
Alan St Clair Gibson ◽  
Iñigo Mujika ◽  
...  
Keyword(s):  
Body Mass ◽  
Muscle Glycogen ◽  
Blood Glucose Concentration ◽  
Controlled Trial ◽  
Liver Glycogen ◽  
Cycling Performance ◽  
Controlled Study ◽  
Mean Power ◽  
Road Racing ◽  
Mean Power Output

We evaluated the effect of carbohydrate (CHO) loading on cycling performance that was designed to be similar to the demands of competitive road racing. Seven well-trained cyclists performed two 100-km time trials (TTs) on separate occasions, 3 days after either a CHO-loading (9 g CHO ⋅ kg body mass− 1 ⋅ day− 1) or placebo-controlled moderate-CHO diet (6 g CHO ⋅ kg body mass− 1 ⋅ day− 1). A CHO breakfast (2 g CHO/kg body mass) was consumed 2 h before each TT, and a CHO drink (1 g CHO ⋅ kg.body mass− 1 ⋅ h− 1) was consumed during the TTs to optimize CHO availability. The 100-km TT was interspersed with four 4-km and five 1-km sprints. CHO loading significantly increased muscle glycogen concentrations (572 ± 107 vs. 485 ± 128 mmol/kg dry wt for CHO loading and placebo, respectively; P < 0.05). Total muscle glycogen utilization did not differ between trials, nor did time to complete the TTs (147.5 ± 10.0 and 149.1 ± 11.0 min; P = 0.4) or the mean power output during the TTs (259 ± 40 and 253 ± 40 W, P = 0.4). This placebo-controlled study shows that CHO loading did not improve performance of a 100-km cycling TT during which CHO was consumed. By preventing any fall in blood glucose concentration, CHO ingestion during exercise may offset any detrimental effects on performance of lower preexercise muscle and liver glycogen concentrations. Alternatively, part of the reported benefit of CHO loading on subsequent athletic performance could have resulted from a placebo effect.

Cognitive Effects of Lyme Disease in Children

PEDIATRICS ◽  
1994 ◽  
Vol 94 (2) ◽  
pp. 185-189
Author(s):  
Wayne V. Adams ◽  
Carlos D. Rose ◽  
Stephen C. Eppes ◽  
Joel D. Klein
Keyword(s):  
Lyme Disease ◽  
Cognitive Skills ◽  
Pediatric Population ◽  
Disease Stage ◽  
Controlled Study ◽  
Fine Motor ◽  
Information Processing Speed ◽  
Duration Of Symptoms ◽  
Healthy Sibling ◽  
Motor Dexterity

Objective. To measure possible cognitive sequelae of Lyme disease (LD) within a pediatric population. Design. Prospective, blinded, controlled study of cognitive skills in children who had been treated for LD. Setting. A children's hospital in an area endemic for LD. Patients. Forty-one children with strictly defined LD were compared with 14 control children who had subacute rheumatological diseases, and with 23 healthy sibling controls. Outcome measures. Neuropsychologic measures were administered to each child to assess the following cognitive areas: IQ, information processing speed, fine-motor dexterity, novel-problem solving and executive functioning, short-term and intermediate memory, and the ability to acquire new learning. Predisease and postdisease academic achievement test scores were also gathered. Impressions from parents concerning the disease's subsequent impact were also obtained. Results. No differences between LD and control groups were found for any of the numerous neuropsychologic measures. Analyses also failed to show differences between LD patients grouped with respect to the presence or absence of known neurologic involvement, disease stage, duration of symptoms before therapy, or type of antibiotic treatment. No predisease versus postdisease difference in academic performance was found. No perceived long-term deterioration in cognitive, social, or personality areas was reported by parents. Conclusion. Children appropriately treated for LD have an excellent prognosis for unimpaired cognitive functioning.

Negligible Effects of β-Hydroxy-β-Methylbutyrate Free Acid and Calcium Salt on Strength and Hypertrophic Responses to Resistance Training: A Randomized, Placebo-Controlled Study

2019 ◽  
Vol 29 (5) ◽  
pp. 505-511 ◽  
Author(s):  
Aline C. Tritto ◽  
Salomão Bueno ◽  
Rosa M.P. Rodrigues ◽  
Bruno Gualano ◽  
Hamilton Roschel ◽  
...  
Keyword(s):  
Resistance Training ◽  
Body Mass ◽  
Muscle Soreness ◽  
Calcium Salt ◽  
Free Acid ◽  
Time Effect ◽  
Controlled Study ◽  
Cross Sectional ◽  
Repetition Maximum ◽  
Leg Press

This study evaluated the effects of β-hydroxy-β-methylbutyrate free acid (HMB-FA) and calcium salt (HMB-Ca) on strength, hypertrophy, and markers of muscle damage. In this randomized, double-blind, placebo-controlled study, 44 resistance-trained men (age: 26 ± 4 years; body mass: 84.9 ± 12.0 kg) consuming ≥1.7 g·kg−1·day−1 of protein received HMB-FA (3 g/day; n = 14), HMB-Ca (3 g/day; n = 15), or placebo (PL; cornstarch, 3 g/day; n = 15) for 12 weeks, while performing a periodized resistance training program. Before and after intervention, lean body mass (measured with dual X-ray absorptiometry), maximal dynamic strength (one-repetition maximum), knee extension maximal isometric strength (maximal voluntary isometric contraction [MVIC]), cross-sectional area (measured with ultrasound), and muscle soreness were assessed. MVIC was also measured 48 hr after the first and the last training sessions. All groups increased lean body mass (main time effect: p < .0001; HMB-FA: 1.8 ± 1.8 kg; HMB-Ca: 0.8 ± 1.4 kg; PL: 0.9 ± 1.4 kg), cross-sectional area (main time effect: p < .0001; HMB-FA: 6.6 ± 3.8%; HMB-Ca: 4.7 ± 4.4%; PL: 6.9 ± 3.8%), one-repetition maximum bench press (main time effect: p < .0001; HMB-FA: 14.8 ± 8.4 kg; HMB-Ca: 11.8 ± 7.4 kg; PL: 11.2 ± 6.6 kg), MVIC (main time effect: p < .0001; HMB-FA: 34.4 ± 39.3%; HMB-Ca: 32.3 ± 27.4%; PL: 17.7 ± 20.9%) after the intervention, but no differences between groups were shown. HMB-FA group showed greater leg press strength after the intervention than HMB-Ca and PL groups (Group × Time interaction: p < .05; HMB-FA: 47.7 ± 31.2 kg; HMB-Ca: 43.8 ± 31.7 kg; PL: 30.2 ± 20.9 kg). MVIC measured 48 hr after the first and the last sessions showed no attenuation of force decline with supplementation. Muscle soreness following the first and last sessions was not different between groups. The authors concluded that neither HMB-Ca nor HMB-FA improved hypertrophy or reduced muscle damage in resistance-trained men undergoing resistance training ingesting optimal amounts of protein. HMB-FA but not HMB-Ca resulted in a statistically significant yet minor improvement on leg press one-repetition maximum.

Differential catecholamine responses to protein intake in healthy and hypertensive subjects

1998 ◽  
Vol 275 (4) ◽  
pp. R1164-R1173 ◽  
Author(s):  
Otto Kuchel
Keyword(s):  
Protein Intake ◽  
Healthy Subjects ◽  
Controlled Study ◽  
Control Subjects ◽  
Urinary Dopamine ◽  
Plasma Tyrosine ◽  
Biological Actions

Protein intake-induced natriuresis previously related to increased urinary dopamine excretion was reexamined in an extensive controlled study comparing healthy and hypertensive subjects. In healthy subjects, ingestion of 1 g/kg wt tuna induced natriuresis that was associated, between postprandial hours 1 and 2, with increased plasma tyrosine [191 ± 13% (mean ± SE); P < 0.01], 3,4-dihydroxyphenylalanine (104 ± 12%, P < 0.05 in plasma; 162 ± 20%, P < 0.05 in urine), plasma free dopamine (156 ± 32%; P < 0.05), and dopamine sulfate (191 ± 11%, P < 0.001 in plasma; 199 ± 15%, P < 0.01 in urine) but affected urinary free dopamine excretion only at limits of significance. Hypertensive subjects had less ( P < 0.02) natriuresis and, despite comparable plasma tyrosine and dopamine sulfate increases, no increase in plasma and urinary 3,4-dihydroxyphenylalanine and plasma free dopamine. Their plasma and urinary free epinephrine responses were less ( P < 0.05) than the borderline increases in control subjects. Compared with control subjects, they significantly increased plasma 3,4-dihydroxyphenylalanine sulfate ( P < 0.05), epinephrine sulfate ( P < 0.05), and the dopamine sulfate-to-free dopamine ratio ( P < 0.02). Postprotein natriuresis is thus associated with nutritional priming-induced plasma but not urinary free dopamine increase. Hypertensive subjects have attenuated natriuretic and plasma free dopamine responses and less free epinephrine increase. This may partly result from higher circulating 3,4-dihydroxyphenylalanine, dopamine, and epinephrine sulfoconjugates leaving fewer free amines for biological actions.

Nasal polyposis: Role of subclinical delayed food hypersensitivity

2000 ◽  
Vol 122 (2) ◽  
pp. 298-301 ◽  
Author(s):  
Yoke-Teen Pang ◽  
Orhan Eskici ◽  
Janet A. Wilson
Keyword(s):  
Food Allergy ◽  
Nasal Polyp ◽  
Nasal Polyposis ◽  
Strong Association ◽  
Food Hypersensitivity ◽  
Postal Survey ◽  
Controlled Study ◽  
Test Results ◽  
Control Subjects

Nasal polyposis is a common problem in otolaryngology. The cause remains unclear, and treatment with medication and surgery is often unsatisfactory. We present our controlled study, which suggests a strong association between food allergy and nasal polyposis. The study was conducted in 2 parts. A postal survey of 900 patients with nasal polyps showed 53 respondents (5.9%) had a known food allergy. In the prospective study, 80 nasal polyp patients and 36 control subjects completed intra-dermal tests for food allergy. Sixty-five nasal polyp patients (81%) and 4 control subjects (11%) had positive intradermal food test results. This is highly significant. We believe that food allergy may play a significant role in the pathogenesis of nasal polyposis and should be further studied.

scholarly journals The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index

2005 ◽  
Vol 153 (2) ◽  
pp. 257-264 ◽  
Author(s):  
Ginevra Corneli ◽  
Carolina Di Somma ◽  
Roberto Baldelli ◽  
Silvia Rovere ◽  
Valentina Gasco ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Gh Deficiency ◽  
Pituitary Hormone ◽  
Obese Patients ◽  
Releasing Hormone ◽  
Gh Secretion ◽  
Control Subjects ◽  
Optimal Separation ◽  
And Control

Objective: The diagnosis of growth hormone (GH) deficiency (GHD) in adults is based on a reduced peak GH response to provocative tests, such as the insulin tolerance test (ITT) and the GH-releasing hormone-arginine (GHRH-ARG) test. However, the cut-off limits of peak GH response in lean subjects are not reliable in obese patients; this is noteworthy since adult GHD is often associated with obesity. Aim of this study was to evaluate the diagnostic cut-off limits of peak GH response to the GHRH-ARG test in overweight and obese as well as in lean population. Design and methods: The GH responses to the GHRH-ARG test were studied in 322 patients with organic hypothalamic-pituitary disease and in 318 control subjects. Patients were subdivided into two groups on the basis of the number of pituitary hormone deficits, except for GH deficiency: (a) patients with total pituitary hormone deficit (TPHD) and (b) patients without or with no more than two pituitary hormone deficits (PHD). Both patients and control subjects were divided into three subgroups according to body mass index (BMI): lean (BMI <25 kg/m2), overweight (BMI ≥25 and <30 kg/m2) and obese (BMI ≥30 kg/m2). TPHD patients were assumed to be GH deficient, whereas PHD patients may include subjects with either normal or impaired GH secretion. The statistical analysis was carried out by the Receiver-Operating Characteristic curve analysis (Medcalc 7.2). The diagnostic cut-off points were calculated for lean, overweight and obese subjects to provide optimal separation of GH-deficient patients and control subjects according to two criteria: (1) a balance between high sensitivity and high specificity; (2) to provide the highest pair of sensitivity/specificity values for GH deficiency. Results: In the lean population the best pair of values, with highest sensitivity as 98.7% and highest specificity as 83.7%, was found using a peak GH cut-off point of 11.5 μg/l. In the overweight population the best pair of values, 96.7 and 75.5%, respectively, was found using a peak GH cut-off point of 8.0 μg/l. In the obese population the best pair of values, 93.5 and 78.3%, respectively, was found using a peak GH cut-off point of 4.2 μg/l. Applying the above mentioned cut-off points, among PHD patients we found that 80 subjects (72%) were GHD whereas 31 (28%) had normal GH secretion. Conclusions: In conclusion the GHRH-ARG test is a reliable tool for the diagnosis of adult GH deficiency in lean, overweight and obese patients, provided that specific BMI-related cut-off limits are assumed.

Economic impact of hyponatremia in hospitalized patients with cancer

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 17053-17053
Author(s):  
M. A. Callahan ◽  
H. T. Do ◽  
D. W. Caplan ◽  
K. Yoon-Flannery ◽  
R. Seifeldin
Keyword(s):  
Hospital Mortality ◽  
Cancer Patients ◽  
Admission Rate ◽  
Cost Of Care ◽  
Hospital Length Of Stay ◽  
Controlled Study ◽  
Severe Hyponatremia ◽  
Accounting Data ◽  
Risk Of Death ◽  
Control Subjects

17053 Background: Hyponatremia, defined as a serum sodium concentration ([Na+]) =134 mEq/L, is a common electrolyte abnormality in hospitalized cancer patients that may be caused by the primary tumor or metastasis, diagnostic or therapeutic interventions, or a secondary complication. Hospital-acquired hyponatremia is associated with higher costs of care, but many patients present with hyponatremia at admission. Methods: This retrospective case-controlled study assessed the outcomes and cost of care among patients hospitalized for neoplasm who presented with hyponatremia at admission. Laboratory and cost-accounting data from 841 adult patients admitted to an 811-bed university hospital between January 2004 and May 2005 with a principal diagnosis of neoplasm and either mild-to- moderate or moderate-to-severe hyponatremia (serum [Na+] 130–134 mEq/L or <130 mEq/L, respectively) were compared with data from control subjects with matching ICD-9 codes and normal serum [Na+] (135–145 mEq/L) at admission during the same period. Endpoints included hospital length of stay (LOS), ICU admissions, in-hospital mortality, and total costs per admission. Results: Hyponatremia was evident in 18.9% of patients admitted for neoplasm. Patients with moderate-to-severe hyponatremia (n=192) and mild-to- moderate hyponatremia (n=649) demonstrated a significantly longer hospital LOS, higher ICU admission rate, higher in-hospital mortality, and higher median costs than control subjects (n=3610) (Table). These differences among groups remained significant after adjustments were made for age, race, sex, and comorbidity score. Conclusions: Cancer patients presenting with hyponatremia at admission have a longer hospital LOS and higher risk of death and cost of care than do cancer patients presenting without hyponatremia. [Table: see text] No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document